VivoSeq
Dermatology

Wound Healing

85

Pipeline Programs↗

17

Active Trials↗

32

Companies Involved↗

Wound Healing is a moderately active landscape with 85 programs across 32 companies. The most active players are Phage Pharmaceuticals, Inc., Viatris Specialty LLC, Novo Nordisk. 9 therapies are approved with 15 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

68/100

Pipeline Velocity

34/100

Mech. Concentration

11/100

Completion Rate

79/100

Attrition Rate

14/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

P

Phage Pharmaceuticals, Inc.

1 program

Phase 1V

Viatris Specialty LLC

1 program

Phase 1Novo Nordisk logo

Novo Nordisk

1 program

Phase 1A

AiViva BioPharma, Inc.

1 program

Phase 2H

Hudson Biotech

1 program

Phase 2N

Neurim Pharmaceuticals Ltd.

1 program

Phase 2

Pipeline

Programs by Phase

Preclinical31

Nicotine

Pfizer

Oxytocin

Retrophin

Morphine

Hikma Pharmaceuticals LLC

Insulin

Merck & Co.

Triamcinolone Acetonide

Bausch Health Americas, Inc.

Phase 19

Syntocinon

Shana McCormack, MD

Phenytoin

Viatris Specialty LLC

Postoperative Medication

Linyi People's Hospital

Dermabond

Icahn School of Medicine at Mount Sinai

Ozonated Oil

Nigde Omer Halisdemir University

Phase 221

Melatonin

Neurim Pharmaceuticals Ltd.

Plerixafor

Genzyme, a Sanofi Company

Pirfenidone

Legacy Health System

Hydromorphone

Rhodes Pharmaceuticals, L.P.

Deferoxamine

Alnylam Pharmaceuticals

Phase 315

Metformin

EMD Serono

Bevacizumab

Bio-Thera Solutions

Propranolol

Wyeth-Lederle Vaccines

Growth Hormone

Pfizer

Oxandrolone

Par Pharmaceutical, Inc.

Approved9

Dexamethasone

Aspen Global Incorporated

Etoricoxib

Novartis

Glutamine Supplementation

Hospital General de Mexico

COE-PAK™

Cairo University

Bluem

Cairo University

Analysis

Modality Breakdown

97%

Small molecule

103 of 106 classified programs — the dominant modality here.

3%ALL OTHERSMonoclonal antibody1<1%Protein / enzyme1<1%Cell therapy1<1%

Small molecule leads; the ring shows all 106 classified programs, each share of the total. Modality classified for 100% of 134 pipeline programs.

Analysis

Trial Status

110

clinical trials

Completed56 · 51%
Unknown status22 · 20%
Terminated8 · 7%
Withdrawn7 · 6%
Recruiting6 · 5%
Active, not recruiting5 · 5%
Other6 · 5%

Clinical Trials

Trial Activity

110 trials

The Effectiveness of Nano Bio Fusion Gingival Gel (NBF) on Wound Healing at the Palate (Donor Site) After Soft Tissue Graft Surgery Compared to Placebo Gel.
Recruiting·KKing Abdullah University Hospital·N/A·NCT07330154·36 enrolled
Comparison of the Effect of Ozonized Gel to That of Photobiomodulation Therapy on Wound Healing Following Surgical Gingivectomy
Recruiting·MMennatullah osama ahmed zaki wahba·N/A·NCT07234994·48 enrolled
Lacripep for Corneal Wound Healing Study
Recruiting·HHenry M. Jackson Foundation for the Advancement of Military Medicine·Phase 2·NCT06854393·88 enrolled
Topical GHK-Cu Gel for Acute Skin Wound Healing
Recruiting·HHudson Biotech·Phase 2·NCT07437586·60 enrolled
4-aminopyridine for Skin Wound Healing
Recruiting·—·Phase 2·NCT06333171·150 enrolled
Palatal Wound Healing After Free Gingival Graft Surgery
Recruiting·KKahramanmaras Sutcu Imam University·N/A·NCT07409571·34 enrolled
Topical Insulin for Postoperative Wound Healing
Active, not recruiting·—·N/A·NCT06400082·74 enrolled
Effect of Topical Active Oxygen Therapy on Surgical Site Wound Healing and Microbial Colonization
Active, not recruiting·—·Phase 1·NCT06705920·44 enrolled
Comparison of I-PRF, T-PRF, and 0.8% Hyaluronic Acid Applications in Wound Healing After Gingivectomy.
Active, not recruiting·SSaglik Bilimleri Universitesi·N/A·NCT06865092·60 enrolled
Wound Healing Endpoint and Recurrence
Active, not recruiting·—·Phase 1/2·NCT02577120·100 enrolled
The Effect of Allogeneic Human Fat-Derived Extract on Skin Graft Donor Site Wound Healing
Active, not recruiting·LLinio Biotech Oy·Preclinical·NCT07372404·30 enrolled
Phase 1 Study of LUT017 Gel to Evaluate Safety and Wound Healing in Adults With Venous Leg Ulcers and Chronic Non-Healing Skin Wounds
Not yet recruiting·—·Phase 1·NCT07463365·18 enrolled
Mailuo Shutong Pills for Diabetic Wound Healing: A Multicenter Randomized Trial
Not yet recruiting·PPeking University Third Hospital·N/A·NCT07258381·56 enrolled
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers
Not yet recruiting·KKarolinska University Hospital·Phase 2·NCT03137966·174 enrolled
Evaluation of the Safety and Efficacy of Dehydrated Human Placenta Tissue (dHPT) for Wound Healing
Not yet recruiting·CCellution Biologics·N/A·NCT07375160·300 enrolled
Page 1 of 8

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)